Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2014
06/19/2014WO2014091007A1 Patch comprising an onion extract
06/19/2014WO2014090981A1 Topical drug for treating aphthae
06/19/2014WO2014090889A1 Oral solutions comprising folic acid
06/19/2014WO2014090842A1 Funny current (if) inhibitors for use in a method of treating and preventing heart disease in canine
06/19/2014WO2014090789A1 Protein conjugates
06/19/2014WO2014090586A1 Delphinidin for combating melanoma cells
06/19/2014WO2014090583A1 Delphinidin for combating melanoma cells
06/19/2014WO2014090185A1 Application of silicon dioxide aerogel in pharmacy
06/19/2014WO2014090176A1 Nanoscale platinum drug and preparation method thereof
06/19/2014WO2014090174A1 Nanoscale capecitabine and preparation method therefor
06/19/2014WO2014090173A1 Nanoscale doxorubicin hydrochloride and preparation method therefor
06/19/2014WO2014090171A1 Nanoscale cyclophosphamide and preparation method thereof
06/19/2014WO2014090169A1 Nanoscale paclitaxel and preparation method thereof
06/19/2014WO2014090168A1 Nanoscale docetaxel and preparation method thereof
06/19/2014WO2014090167A1 Nanoscale insulin and preparation method thereof
06/19/2014WO2014090128A1 Arteannuin cyclodextrin conjugate and preparing method thereof
06/19/2014WO2014090127A1 Cyclodextrin carrier-based arteannuin compound conjugate and preparing method thereof
06/19/2014WO2014089957A1 Stable busulfan injection
06/19/2014WO2014077712A8 Solid lipid nanoparticles of roxithromycin for hair loss or acne
06/19/2014WO2014045022A3 Agents and methods
06/19/2014US20140171629 Medicinal agent for medical applications
06/19/2014US20140171521 Highly functional cellulose composite
06/19/2014US20140171520 Highly soluble stevia sweetener
06/19/2014US20140171519 Compositions and methods for improving rebaudioside x solubility
06/19/2014US20140171518 Stable and compatible polymer blends
06/19/2014US20140171514 Nmda receptor antagonist formulation with reduced neurotoxicity
06/19/2014US20140171510 Homoarginine prodrugs and/or conjugates of amphetamine and other stimulants and processes for making and using the same
06/19/2014US20140171495 Stable pharmaceutical formulation of cabazitaxel
06/19/2014US20140171490 Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
06/19/2014US20140171482 Nanotubes as Carriers of Nucleic Acids into Cells
06/19/2014US20140171464 Pharmaceutical composition containing diamine derivative
06/19/2014US20140171441 Pharmaceutical compositions with enhanced performance
06/19/2014US20140171398 Formoterol/steroid bronchodilating compositions and methods of use thereof
06/19/2014US20140171387 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
06/19/2014US20140171375 Macromolecules
06/19/2014US20140171370 Formulations of active agents for sustained release
06/19/2014US20140171369 Pharmaceutical Composition
06/19/2014US20140171368 Polyanion nanocomplexes for therapeutic applications
06/19/2014US20140171367 Polymer Hydrogels For In Vivo Applications And Methods For Using And Preparing Same
06/19/2014US20140171366 Compounds and methods for treating cancer
06/19/2014US20140171364 Stable glucagon formulations for the treatment of hypoglycemia
06/19/2014US20140170221 Methods and compositions for localized delivery of agents to virally infected cells and tissues
06/19/2014US20140170219 Composition and method for treating hpv
06/19/2014US20140170206 Composition for the transdermal delivery of fentanyl
06/19/2014US20140170197 Polymeric delivery systems for active agents
06/19/2014US20140170195 Anhydrous Powder-to-Liquid Particles
06/19/2014US20140170185 Emulsion containing a non-live medicinal substance
06/19/2014US20140170183 D-Amino Acid Derivative-Modified Peptidoglycan and Methods of Use Thereof
06/19/2014US20140170175 Novel lipids and compositions for intracellular delivery of biologically active compounds
06/19/2014US20140170174 Polychlorinated biphenyls and squalene-containing adjuvants
06/19/2014US20140170172 Tat-Based Tolerogen Compositions and Methods for Making and Using Same
06/19/2014US20140170171 Targeted cytokine for treatment of musculoskeletal diseases
06/19/2014US20140170149 Bispecific antibodies against her2 and cd3
06/19/2014US20140170148 Bispecific antibodies against her2
06/19/2014US20140170142 Molecules With Extended Half-Lives And Uses Thereof
06/19/2014US20140170140 Compositions and methods for the treatment of neuromyelitis optica
06/19/2014US20140170082 Flavor-improving method
06/19/2014US20140170076 Anti-nucleolin agent-conjugated nanoparticles
06/19/2014US20140170070 Stable colloidal gold nanoparticles with controllable surface modification and functionalization
06/19/2014US20140170065 Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments
06/19/2014US20140170063 Dosages of Immunoconjugates of Antibodies and SN-38 for Improved Efficacy and Decreased Toxicity
06/19/2014US20140166024 Mouthguard for the delivery of active ingredients
06/18/2014EP2743277A1 Highly functional cellulose composite
06/18/2014EP2742957A1 Polyethylene glycol derivatives of palmitoylethanolamide and analogous acylethanolamides
06/18/2014EP2742956A1 Medicinal agent for medical applications, and method for searching for novel medicinal agent
06/18/2014EP2742955A1 Nanoparticles based on bioconjugate of GAG
06/18/2014EP2742954A1 "Silymarin aqueous formulation"
06/18/2014EP2742943A1 Composition containing s-adenosyl-l-methionine with excellent storage stability
06/18/2014EP2742941A1 Pharmaceutical composition containing diamine derivative
06/18/2014EP2742932A1 Gel compositions
06/18/2014EP2742931A1 Topical drug for treating ulcers
06/18/2014EP2742146A2 Stabilized compositions against ionising radiation
06/18/2014EP2742070A1 Degradation-resistant cross-linked, low-molecular-weight hyaluronate
06/18/2014EP2741823A1 Methods and compositions for improving sperm functionality
06/18/2014EP2741783A1 Polyanion nanocomplexes for therapeutic applications
06/18/2014EP2741782A1 Protein carrier-linked prodrugs
06/18/2014EP2741781A1 Carrier-linked treprostinil prodrugs
06/18/2014EP2741780A1 Method for the controlled intracellular delivery of nucleic acids
06/18/2014EP2741779A1 High-loading water-soluble carrier-linked prodrugs
06/18/2014EP2741778A1 Polymeric hyperbranched carrier-linked prodrugs
06/18/2014EP2741777A1 Methods and pharmaceutical compositions for treatment of pulmonary hypertension
06/18/2014EP2741775A1 Polymeric nanoparticles for photosensitizers
06/18/2014EP2741765A1 Injectable solution of at least one type of basal insulin
06/18/2014EP2741757A1 Compositions of functional mitochondria and uses thereof
06/18/2014EP2741750A1 Pharmaceutical composition comprising cefuroxime
06/18/2014EP2741748A1 Beta-lactam compounds for enhancing t cell-mediated immune responses
06/18/2014EP2741744A1 Carrier-linked prodrugs having reversible carboxylic ester linkages
06/18/2014EP2741738A1 Sustained release composition of prostacyclin
06/18/2014EP2741731A1 Encapsulates
06/18/2014EP2741730A1 Multiple emulsion
06/18/2014CN103874722A Method for manufacturing block copolymer
06/18/2014CN103874512A Selective delivery molecules and methods of use
06/18/2014CN103874511A Brain tumor targeting peptides and methods
06/18/2014CN103874485A Formulations and dosage forms of oxidized phospholipids
06/18/2014CN103874482A Liposome composite body
06/18/2014CN103874480A Sustained release composition of prostacyclin
06/18/2014CN103865899A Fusion toxin with specificity of VEGFR2/KDR acceptor, and coding gene and application thereof
06/18/2014CN103865069A Active targeting star polymer carrier with physiological environment response function and preparation method thereof
06/18/2014CN103865056A Nonlinear polymer containing doxorubicin structure, and preparation method and application thereof
06/18/2014CN103865049A Amphiphilic block polymer as well as preparation method and application of amphiphilic block polymer
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 1712